Publications

Export 13 results:
Auteur Title [ Type(Desc)] Année
Filtres: Auteur is Chillotti, Caterina  [Enlever les filtres]
Journal Article
Reinbold CS, Forstner AJ, Hecker J, Fullerton JM, Hoffmann P, Hou L, Heilbronner U, Degenhardt F, Adli M, Akiyama K et al..  2018.  Analysis of the Influence of microRNAs in Lithium Response in Bipolar Disorder.. Front Psychiatry. 9:207.
Amare AT, Schubert KOliver, Hou L, Clark SR, Papiol S, Cearns M, Heilbronner U, Degenhardt F, Tekola-Ayele F, Hsu Y-H et al..  2020.  Association of polygenic score for major depression with response to lithium in patients with bipolar disorder.. Mol Psychiatry.
Amare AT, Schubert KOliver, Hou L, Clark SR, Papiol S, Heilbronner U, Degenhardt F, Tekola-Ayele F, Hsu Y-H, Shekhtman T et al..  2018.  Association of Polygenic Score for Schizophrenia and HLA Antigen and Inflammation Genes With Response to Lithium in Bipolar Affective Disorder: A Genome-Wide Association Study.. JAMA Psychiatry. 75(1):65-74.
Lin R, Lopez JPablo, Cruceanu C, Pierotti C, Fiori LM, Squassina A, Chillotti C, Dieterich C, Mellios N, Turecki G.  2021.  Circular RNA circCCNT2 is upregulated in the anterior cingulate cortex of individuals with bipolar disorder.. Transl Psychiatry. 11(1):629.
Schubert KOliver, Thalamuthu A, Amare AT, Frank J, Streit F, Adl M, Akula N, Akiyama K, Ardau R, Arias B et al..  2021.  Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients.. Transl Psychiatry. 11(1):606.
Papadima EMerkouri, Niola P, Melis C, Pisanu C, Congiu D, Cruceanu C, Lopez JPablo, Turecki G, Ardau R, Severino G et al..  2017.  Evidence towards RNA Binding Motif (RNP1, RRM) Protein 3 (RBM3) as a Potential Biomarker of Lithium Response in Bipolar Disorder Patients.. J Mol Neurosci. 62(3-4):304-308.
Hou L, Heilbronner U, Degenhardt F, Adli M, Akiyama K, Akula N, Ardau R, Arias B, Backlund L, Banzato CEM et al..  2016.  Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study.. Lancet. 387(10023):1085-93.
Hou L, Bergen SE, Akula N, Song J, Hultman CM, Landen M, Adli M, Alda M, Ardau R, Arias B et al..  2016.  Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder.. Hum Mol Genet. 25(15):3383-3394.
Le Clerc S, Lombardi L, Baune BT, Amare AT, Schubert KOliver, Hou L, Clark SR, Papiol S, Cearns M, Heilbronner U et al..  2021.  HLA-DRB1 and HLA-DQB1 genetic diversity modulates response to lithium in bipolar affective disorders.. Sci Rep. 11(1):17823.
Kalman JL, Papiol S, Forstner AJ, Heilbronner U, Degenhardt F, Strohmaier J, Adli M, Adorjan K, Akula N, Alda M et al..  2018.  Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study.. Bipolar Disord.
Squassina A, Pisanu C, Congiu D, Caria P, Frau D, Niola P, Melis C, Baggiani G, Lopez JPablo, Cruceanu C et al..  2016.  Leukocyte telomere length positively correlates with duration of lithium treatment in bipolar disorder patients.. Eur Neuropsychopharmacol. 26(7):1241-7.
Niola P, Gross JA, Lopez JPablo, Chillotti C, Deiana V, Manchia M, Georgitsi M, Patrinos GP, Alda M, Turecki G et al..  2014.  Lithium-induced differential expression of SAT1 in suicide completers and controls is not correlated with polymorphisms in the promoter region of the gene.. Psychiatry Res. 220(3):1167-8.
Squassina A, Niola P, Lopez JPablo, Cruceanu C, Pisanu C, Congiu D, Severino G, Ardau R, Chillotti C, Alda M et al..  2020.  MicroRNA expression profiling of lymphoblasts from bipolar disorder patients who died by suicide, pathway analysis and integration with postmortem brain findings.. Eur Neuropsychopharmacol. 34:39-49.